Epoch Investment Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$105M Sell
268,670
-144,227
-35% -$61M 0.6% 54
2026
Q1
$195M Sell
412,897
-59,842
-13% -$30.1M 1.18% 11
2025
Q4
$221M Sell
472,739
-32,805
-6% -$15.2M 1.25% 10
2025
Q3
$215M Sell
505,544
-115,502
-19% -$44.8M 1.18% 12
2025
Q2
$238M Sell
621,046
-73,860
-11% -$26.6M 1.23% 11
2025
Q1
$240M Sell
694,906
-61,604
-8% -$19.8M 1.25% 9
2024
Q4
$227M Buy
756,510
+93,219
+14% +$32.6M 1.1% 16
2024
Q3
$270M Buy
663,291
+31,437
+5% +$11.5M 1.21% 9
2024
Q2
$203M Buy
631,854
+88,948
+16% +$28.9M 0.93% 21
2024
Q1
$181M Buy
542,906
+85,505
+19% +$26.1M 0.81% 26
2023
Q4
$124M Buy
457,401
+312,687
+216% +$77.3M 0.56% 47
2023
Q3
$35.6M Buy
144,714
+64,602
+81% +$17.7M 0.23% 149
2023
Q2
$24.3M Buy
+80,112
New +$22.3M 0.14% 190

Other funds holding HCA

Epoch Investment Partners's HCA Position: Q2 2026 in Review

Epoch Investment Partners reduced its HCA Healthcare (HCA) stake by 35% in Q2 2026, selling an estimated $61M and leaving 268,670 shares worth $105M. The position accounts for 0.6% of the portfolio, ranked #54.

Epoch Investment Partners first reported a position in HCA in Q2 2023 and has held it in 13 quarters since. The position peaked at $270M in Q3 2024. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Epoch Investment Partners held 268,670 shares of HCA Healthcare worth $105M as of Q2 2026.
  • Epoch Investment Partners sold 144,227 HCA Healthcare shares in Q2 2026, an estimated $61M.
  • HCA Healthcare made up 0.6% of Epoch Investment Partners's portfolio in Q2 2026, its #54 holding.
  • Epoch Investment Partners first reported a position in HCA Healthcare in Q2 2023 and has held it in 13 quarters since.
  • Epoch Investment Partners's HCA Healthcare position peaked at $270M in Q3 2024.
  • 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Epoch Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.